Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Inventory (2018 - 2025)

AVITA Medical (RCEL) has disclosed Inventory for 5 consecutive years, with $6.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Inventory fell 4.72% year-over-year to $6.9 million, compared with a TTM value of $6.9 million through Dec 2025, down 4.72%, and an annual FY2025 reading of $6.9 million, down 4.72% over the prior year.
  • Inventory was $6.9 million for Q4 2025 at AVITA Medical, down from $7.2 million in the prior quarter.
  • Across five years, Inventory topped out at $8.4 million in Q1 2025 and bottomed at $1.8 million in Q1 2022.
  • Average Inventory over 4 years is $5.1 million, with a median of $5.9 million recorded in 2023.
  • The sharpest move saw Inventory surged 163.34% in 2023, then dropped 4.72% in 2025.
  • Year by year, Inventory stood at $2.1 million in 2022, then soared by 163.34% to $5.6 million in 2023, then grew by 29.9% to $7.3 million in 2024, then dropped by 4.72% to $6.9 million in 2025.
  • Business Quant data shows Inventory for RCEL at $6.9 million in Q4 2025, $7.2 million in Q3 2025, and $7.5 million in Q2 2025.